BR0210804A - Vacinação de dose única com mycoplásma hyopneumoniae - Google Patents

Vacinação de dose única com mycoplásma hyopneumoniae

Info

Publication number
BR0210804A
BR0210804A BR0210804-6A BR0210804A BR0210804A BR 0210804 A BR0210804 A BR 0210804A BR 0210804 A BR0210804 A BR 0210804A BR 0210804 A BR0210804 A BR 0210804A
Authority
BR
Brazil
Prior art keywords
vaccine
single dose
mycoplasma hyopneumoniae
hyo
dose vaccination
Prior art date
Application number
BR0210804-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Robin Lee Keich
Lisa Grace Sabbadini
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0210804(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0210804A publication Critical patent/BR0210804A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0210804-6A 2001-07-02 2002-06-07 Vacinação de dose única com mycoplásma hyopneumoniae BR0210804A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en) 2001-07-02 2002-06-07 One dose vaccination with mycoplasma hyopneumoniae

Publications (1)

Publication Number Publication Date
BR0210804A true BR0210804A (pt) 2005-05-03

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210804-6A BR0210804A (pt) 2001-07-02 2002-06-07 Vacinação de dose única com mycoplásma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (https=)
EP (3) EP2027873B8 (https=)
JP (1) JP2005515162A (https=)
KR (1) KR20040030785A (https=)
CN (3) CN102872456B (https=)
AP (1) AP2003002937A0 (https=)
AR (1) AR034678A1 (https=)
AT (1) ATE412426T2 (https=)
AU (1) AU2002309109B2 (https=)
BG (1) BG66481B1 (https=)
BR (1) BR0210804A (https=)
CA (1) CA2451626C (https=)
CY (1) CY1108749T1 (https=)
CZ (1) CZ305781B6 (https=)
DE (1) DE60229666D1 (https=)
DK (3) DK1474067T4 (https=)
DO (1) DOP2002000431A (https=)
EA (1) EA009901B1 (https=)
ES (3) ES2312580T5 (https=)
GT (1) GT200200138A (https=)
HK (1) HK1207584A1 (https=)
HR (1) HRP20031079A2 (https=)
HU (1) HU230246B1 (https=)
IL (1) IL159349A0 (https=)
IS (1) IS7076A (https=)
MA (1) MA27047A1 (https=)
MX (1) MXPA03011599A (https=)
NO (1) NO342654B1 (https=)
NZ (1) NZ530106A (https=)
OA (1) OA12638A (https=)
PA (1) PA8549701A1 (https=)
PE (1) PE20030285A1 (https=)
PL (1) PL209773B1 (https=)
PT (3) PT2027873E (https=)
SK (1) SK288010B6 (https=)
TN (1) TNSN03155A1 (https=)
TW (1) TWI329514B (https=)
UA (1) UA78707C2 (https=)
UY (1) UY27366A1 (https=)
WO (1) WO2003003941A2 (https=)
YU (1) YU102203A (https=)
ZA (1) ZA200309698B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015192196A1 (pt) * 2014-06-16 2015-12-23 Ouro Fino Saúde Animal Ltda Complexo de poliproteínas imunogênicas de m. hyopneumoniae, gene sintético codificante do complexo de poliproteínas imunogênicas de m. hyopneumoniae, composição antigênica, processo de obtenção de um complexo de poliprotenas imunogênicas de m. hyopneumoniae, uso de uma composição baseada no complexo de poliproteínas imunogênicas de m. hyopneumoniae

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
DK3766518T3 (da) 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
EP3868400A1 (en) 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
KR20080100384A (ko) * 2006-03-03 2008-11-17 메리얼 리미티드 마이코플라즈마 하이오뉴모니아에 백신
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) * 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2217271B1 (en) * 2007-11-06 2016-05-04 Zoetis Services LLC Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
MX2010014026A (es) 2008-06-27 2011-02-15 Pfizer Composiciones adyuvantes novedosas.
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
NZ702796A (en) * 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
BR112013004594B1 (pt) * 2010-08-27 2020-07-28 Intervet International B. V. método para a determinação de um conteúdo de antígeno
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
BR112014022067B1 (pt) * 2012-03-07 2022-05-31 Ceva Sante Animale Composição compreendendo antígeno e lipopolissacarídeo
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
MX361273B (es) 2012-12-28 2018-12-03 Boehringer Ingelheim Vetmedica Gmbh Metodo para obtener una vacuna de mycoplasma.
AU2013370982C9 (en) * 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
KR101764750B1 (ko) * 2013-02-05 2017-08-03 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
KR101943171B1 (ko) 2013-09-19 2019-01-29 조에티스 서비시즈 엘엘씨 유성 아쥬반트
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
BR112016010427B1 (pt) * 2013-11-21 2020-06-02 Agricultural Technology Research Institute Composição para prevenir infecção por mycoplasma spp., vetor de expressão, e método para prepararantígeno solúvel
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
DK3244920T5 (da) 2015-01-16 2024-10-07 Zoetis Services Llc Mund- og klovsyge-vaccine
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING PORCINE MYCOPLASMA INFECTIONS WITH RECOMBINANT PROTEIN
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
CA2078131A1 (en) 1990-04-02 1991-10-03 Jerry M. Kuner Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
ES2112274T5 (es) 1990-05-29 2006-03-01 Wyeth Holdings Corporation Vacuna contra la pneumonia en cerdos y metodo para la preparacion de la misma.
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
EP0839050B1 (en) 1992-09-28 2004-08-11 Wyeth Holdings Corporation Method of enhancing cell mediated immune responses
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
PT968722E (pt) 1994-05-10 2007-09-06 Wyeth Corp Vacina viva melhorada contra brsv.
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
BR9713312B1 (pt) 1996-09-30 2009-08-11 preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
AU1535299A (en) 1997-11-26 1999-06-15 Iowa State University Research Foundation Inc. Recombinant (mycoplasma hyopneumoniae) vaccine
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015192196A1 (pt) * 2014-06-16 2015-12-23 Ouro Fino Saúde Animal Ltda Complexo de poliproteínas imunogênicas de m. hyopneumoniae, gene sintético codificante do complexo de poliproteínas imunogênicas de m. hyopneumoniae, composição antigênica, processo de obtenção de um complexo de poliprotenas imunogênicas de m. hyopneumoniae, uso de uma composição baseada no complexo de poliproteínas imunogênicas de m. hyopneumoniae

Also Published As

Publication number Publication date
PT1474067E (pt) 2008-11-14
EP1474067A4 (en) 2005-08-10
EP2842569B1 (en) 2019-04-10
DK2027873T3 (en) 2015-11-09
UY27366A1 (es) 2003-04-30
ZA200309698B (en) 2014-04-30
SK15792003A3 (sk) 2005-09-08
UA78707C2 (en) 2007-04-25
WO2003003941A2 (en) 2003-01-16
CY1108749T1 (el) 2014-04-09
EA009901B1 (ru) 2008-04-28
PE20030285A1 (es) 2003-03-27
US6846477B2 (en) 2005-01-25
HK1134900A1 (zh) 2010-05-20
ES2312580T5 (es) 2017-12-11
HK1207584A1 (en) 2016-02-05
EP2027873B1 (en) 2015-09-09
HK1068250A1 (en) 2005-04-29
MA27047A1 (fr) 2004-12-20
BG108546A (bg) 2005-02-28
HRP20031079A2 (en) 2005-10-31
CN101524532A (zh) 2009-09-09
CZ305781B6 (cs) 2016-03-16
US20030109473A1 (en) 2003-06-12
AR034678A1 (es) 2004-03-03
CA2451626C (en) 2011-05-31
EP1474067B2 (en) 2017-08-16
CN1551781A (zh) 2004-12-01
YU102203A (sh) 2006-05-25
CZ20033466A3 (cs) 2005-06-15
CN102872456B (zh) 2016-01-20
IL159349A0 (en) 2004-06-01
TNSN03155A1 (fr) 2005-12-23
ES2729579T3 (es) 2019-11-04
CN101524532B (zh) 2014-03-19
AU2002309109B2 (en) 2007-12-13
NO20035762L (no) 2004-02-02
EP1474067A2 (en) 2004-11-10
JP2005515162A (ja) 2005-05-26
PL373367A1 (en) 2005-08-22
AP2003002937A0 (en) 2003-12-31
DK1474067T4 (en) 2017-10-16
HK1180224A1 (zh) 2013-10-18
CN102872456A (zh) 2013-01-16
EP2027873B8 (en) 2015-11-11
CN1551781B (zh) 2013-01-02
EA200301323A1 (ru) 2005-06-30
ATE412426T2 (de) 2008-11-15
USRE44399E1 (en) 2013-07-30
TWI329514B (en) 2010-09-01
EP1474067B1 (en) 2008-10-29
HU230246B1 (hu) 2015-11-30
CA2451626A1 (en) 2003-01-16
OA12638A (en) 2006-06-15
DOP2002000431A (es) 2003-01-15
HUP0400434A2 (en) 2007-08-28
US20050013823A1 (en) 2005-01-20
PA8549701A1 (es) 2003-01-24
WO2003003941A3 (en) 2004-07-29
KR20040030785A (ko) 2004-04-09
GT200200138A (es) 2003-05-15
ES2312580T3 (es) 2009-03-01
PT2842569T (pt) 2019-06-17
PT2027873E (pt) 2015-11-03
SK288010B6 (sk) 2012-10-02
DE60229666D1 (de) 2008-12-11
BG66481B1 (bg) 2015-02-27
PL209773B1 (pl) 2011-10-31
IS7076A (is) 2003-12-15
MXPA03011599A (es) 2005-03-07
NZ530106A (en) 2007-06-29
NO342654B1 (no) 2018-06-25
DK2842569T3 (da) 2019-05-20
DK1474067T3 (da) 2008-12-08
EP2027873A1 (en) 2009-02-25
EP2842569A1 (en) 2015-03-04
ES2550458T3 (es) 2015-11-10

Similar Documents

Publication Publication Date Title
BR0210804A (pt) Vacinação de dose única com mycoplásma hyopneumoniae
BR0211049A (pt) Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
BR0210798A (pt) vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais
BRPI0010612B8 (pt) vacinas
BR0212999A (pt) novas composições imunogênicas para a prevenção e tratamento de doença meningocócica
BRPI0409459A (pt) novas composições imunogênicas para a prevenção e tratamento de doença meningocócica
BR0011737A (pt) Vacina de poxvìrus recombinante de circovìrus de porcino
BRPI0614119B8 (pt) vacina para imunizar gatos contra calicivírus de felino
BR9909483A (pt) Derivados de proteìnas ligantes pneumococcal colina para vacinas
BR0316685A (pt) Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
PT777499E (pt) Vacina viva para tratamento de doencas tumorais
BR0013252A (pt) Micofenolato mofetila em associação com peg-ifn-alfa
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
TWI871759B (zh) 豬流行性下痢病毒之dna疫苗及其應用
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
HN2002000163A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
TH64472A (th) การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae
Shewen Department of Veterinary Microbiology and Immunology Ontario Veterinary College University of Guelph Guelph, Canada N1G 2W1
Crocket Tuberculin
JP2002020314A (ja) 免疫化組成物における免疫性アジュバントとしての糖エーテルの使用、それらを含有する治療用組成物、および該組成物のワクチンとしての使用
UA12940U (en) Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals
UA57299A (uk) Спосіб виготовлення вакцини проти вірусної геморагічної хвороби кролів

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 10 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.